Español
Questions About Cancer? 1-800-4-CANCER

All News Releases

Moffitt researchers participate in HPV international phase 2/3 trial
NCI Cancer Center News
(Posted: 02/23/2015) - A pivotal international phase 2/3 clinical trial involving Moffitt Cancer Center faculty demonstrated that vaccination with Gardasil 9 protects against nine HPV types, seven of which cause most cases of cervical, vulvar, and vaginal disease.

MD Anderson researchers find that breast cancer spread may be tied to cells that regulate blood flow
NCI Cancer Center News
(Posted: 02/20/2015) - Scientists at the University of Texas MD Anderson Cancer Center believe that targeting blood vessel cells known as pericytes may offer a potential new therapeutic approach when combined with vascular growth factors responsible for cell death.

Yale researchers find that sunlight continues to damage skin in the dark
NCI Cancer Center News
(Posted: 02/20/2015) - Much of the damage that ultraviolet radiation does to skin occurs hours after sun exposure, a team of Yale-led researchers concluded.

USC researchers find new target for prostate cancer treatment
NCI Cancer Center News
(Posted: 02/20/2015) - Scientists have found a promising new therapeutic target for prostate cancer. The findings offer evidence that a newly discovered member of a family of cell surface proteins called G-protein coupled receptors (GPCRs) promotes prostate cancer cell growth.

Mayo researchers identify gene that pushes normal pancreas cells to change shape
NCI Cancer Center News
(Posted: 02/20/2015) - A research team led by investigators from Mayo Clinic have identified a molecule that pushes normal pancreatic cells to transform their shape, laying the groundwork for development of pancreatic cancer -- one of the most difficult tumors to treat.

Brigham and Women's Hospital present study for predicting cancers' cell of origin
Cancer Center News
(Posted: 02/19/2015) - A study led by researchers from Brigham and Women's Hospital suggests a new way to trace cancer back to its cell type of origin.

Washington University researchers use camel and alpaca antibodies to target anticancer viruses directly to tumors
Cancer Center News
(Posted: 02/19/2015) - Using antibodies from camels and alpacas, scientists at Washington University School of Medicine in St. Louis have found a way to deliver anticancer viruses directly to tumor cells, leaving other types of cells uninfected.

U Penn researchers develop personalized cellular therapy for brain cancer in mice
Cancer Center News
(Posted: 02/19/2015) - Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells.

Thomas Jefferson University study reveals how to improve chemotherapy use in prostate cancer
Cancer Center News
(Posted: 02/18/2015) - Next generation chemotherapy for prostate cancer has unique properties that could make it more effective earlier in treatment if confirmed in clinical trials.

St. Jude research finds that survivors of childhood cancer at risk for developing hormone deficiencies as adults
Cancer Center News
(Posted: 02/17/2015) - St. Jude Children’s Research Hospital finds childhood cancer patients treated with cranial irradiation may have hormone deficiencies that impact health decades later; results highlight need for lifelong health screenings.

< Previous  1 2 3 4 5 6 7 8 9 10 11 12  Next >